Take Five: Coronavirus vaccine race is on

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/14/2026

1. DPZ
2. NVDA
3. BAC
4. UNH
5. ORCL
6. AVAV
7. META
8. VSTM
9. GS
10. DVLT

Go back to Take Five: Coronavirus vaccine race is on

Novavax (NVAX) Begins Phase 1/2 Clinical Trial of COVID-19 Vaccine

May 26, 2020 5:53 AM EDT

Novavax, Inc. (NASDAQ: NVAX) today announced enrollment of the first participants in a Phase 1/2 clinical trial of its coronavirus vaccine candidate, NVXCoV2373, a stable, prefusion protein made using its proprietary nanoparticle technology. NVXCoV2373 includes Novavax proprietary MatrixM adjuvant to enhance immune responses and stimulate high levels of neutralizing antibodies. Preliminary immunogenicity and safety results from the Phase 1 portion of the trial are expected in July 2020.

Administering our vaccine in the first participants of this clinical trial is a significant achievement, bringing us one step closer toward addressing the... More